IKZF2 and ovarian carcinoma: However, CK1α is not the only protein with this characteristic, and therefore dual degraders have been developed which target CK1α and Helios (IKZF2), which have demonstrated efficacy in cell lines representing ovarian cancer and diffuse large B cell lymphoma [109,110].